- Status:
- Topic selection
- Technology type:
- Medicine
- Decision:
- Not selected
- Reason for decision:
- Not eligible for Health Technology Evaluation guidance
- Further information:
- Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. As is consistent with decisions made relating to other semaglutide products for treating type 2 diabetes, your product will now be routed to the NICE Centre for Guidelines where the topic will be considered as part of the ongoing update to NG28 Project information | Type 2 diabetes in adults: management (medicines update) | Guidance | NICE.
- ID number:
- 11791
Project Team
- Project lead
- Danielle Lees
Email enquiries
If you have any queries please email [email protected]
For further information on how we select topics for development, please see our page about prioritising our guidance topics